Whittier Trust’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.67K Hold
312
﹤0.01% 1188
2026
Q1
$5.12K Sell
312
-99
-24% -$2.15K ﹤0.01% 1203
2025
Q4
$10.7K Hold
411
﹤0.01% 1123
2025
Q3
$9.36K Buy
411
+99
+32% +$2.04K ﹤0.01% 1128
2025
Q2
$6.2K Hold
312
﹤0.01% 1307
2025
Q1
$5.27K Hold
312
﹤0.01% 1313
2024
Q4
$5.76K Hold
312
﹤0.01% 1350
2024
Q3
$6.78K Hold
312
﹤0.01% 1335
2024
Q2
$6.12K Buy
+312
New +$6.51K ﹤0.01% 1321

Other funds holding FLGT

Whittier Trust's FLGT Position: Q2 2026 in Review

Whittier Trust held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 312 shares worth $6.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Whittier Trust first reported a position in FLGT in Q2 2024 and has held it in 9 quarters since. The position peaked at $10.7K in Q4 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Whittier Trust held 312 shares of Fulgent Genetics worth $6.67K as of Q2 2026.
  • Whittier Trust left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #1188 holding.
  • Whittier Trust first reported a position in Fulgent Genetics in Q2 2024 and has held it in 9 quarters since.
  • Whittier Trust's Fulgent Genetics position peaked at $10.7K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.